Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

11:30AM EDT

World markets

Shanghai 4,229.27 -69.44 (-1.62%)
Nikkei 225 19,531.63
Hang Seng Index 27,640.91 -114.63 (-0.41%)
TSEC 9,818.20 -1.93 (-0.02%)
FTSE 100 6,934.47 +6.89 (0.10%)
EURO STOXX 50 3,560.39 +13.83 (0.39%)
CAC 40 4,982.96 +8.89 (0.18%)
S&P TSX 14,983.51 -190.43 (-1.25%)
S&P/ASX 200 5,692.20 -134.30 (-2.30%)
BSE Sensex 26,717.37 -722.77 (-2.63%)
TA25 1,622.31 -8.44 (-0.52%)
SMI 8,880.64 -143.74 (-1.59%)
ATX 2,568.98 -14.95 (-0.58%)
IBOVESPA 57,701.27 -350.34 (-0.60%)
SET 1,519.88 -6.86 (-0.45%)
BIST100 82,441.37 -939.30 (-1.13%)
IBEX 11,164.10 +48.50 (0.44%)
WIG 56,928.56 +486.31 (0.86%)
TASI 9,781.69
MERVAL 11,188.13 +35.66 (0.32%)

Currencies

EUR/USD 1.1336 +0.0153 (1.37%)
USD/JPY 119.4450 -0.4965 (-0.41%)
GBP/USD 1.5250 +0.0078 (0.51%)
USD/CAD 1.1982 -0.0088 (-0.73%)
USD/HKD 7.7522 +0.0011 (0.01%)
USD/CNY 6.2020 -0.0008 (-0.01%)
AUD/USD 0.8011 +0.0080 (1.01%)

Bonds

3 Month 0.01% +0.01 (∞%)
6 Month 0.08% +0.02 (33.33%)
2 Year 0.62% +0.01 (1.64%)
5 Year 1.57% +0.03 (1.95%)
10 Year 2.22% +0.03 (1.37%)
30 Year 2.95% +0.04 (1.37%)
Alexion to Buy Synageva BioPharma in $8.4 Billion Deal
Alexion Pharmaceuticals has become one of the most valuable companies in the biotechnology industry on the strength of a single drug that treats two extremely rare diseases.
Alexion Pharma to buy Synageva BioPharma for $8.4 billion  
Alexion Buying Synageva For $230 A Share; Stock Slips ALXN GEVA  
Market Chart
17,869.04 -59.16 (-0.33%)
2,084.59 -4.87 (-0.23%)
4,928.88 -10.45 (-0.21%)

Top stories

WASHINGTON (Reuters) - Federal Reserve Chair Janet Yellen on Wednesday said high equity valuations could pose potential dangers but that stability risks across the U.S.
BRUSSELS´┐ŻThe European Union unveiled a signature plan to unite the region's fragmented online markets and crack down on possible abuses by U.S.
Investing.com - U.S. non-farm private employment rose less than expected in April, fuelling concerns over the strength of the U.S.
WASHINGTON - U.S. productivity in the first quarter fell by a 1.9% annual pace, resulting in the first back-to-back drop since 2006.
Wendy's Co. announced plans Wednesday to sell off its Ohio bun-making business this month, while the burger chain provided greater detail about plans to sell off more than 600 of its company-owned restaurants to franchisees.

Trends

Popular searches on GoogleChange Mkt Cap
FRO Frontline Ltd. -2.02% 2.12B

Sector summary

Sector Change % down / up
Energy +0.16%
Basic Materials -0.05%
Industrials +0.01%
Cyclical Cons. Goods ... -0.27%
Non-Cyclical Cons. Goods... +0.56%
Financials -0.17%
Healthcare -0.06%
Technology -0.42%
Telecommunications Servi... -0.22%
Utilities -0.82%